[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
:: Volume 15, Issue 2 (12-2021) ::
Iran J Virol 2021, 15(2): 22-27 Back to browse issues page
Comparing the molecular and serological testing for detection of SARS - COV-2
Delara Laghousi , Hossein Bannazadeh Baghi , Vahdat Poortahmasebi , Arezou Azadi, Robab Nomani, Muslim Ghasemi Nia, Javid Sadeghi , Mahin Ahangar Oskouee
2. Infectious and Tropical Diseases Research Center, Immunology Research Center , Department of Microbiology & Virology, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract:   (398 Views)
Background and Aims: The exact protective antibody to the SARS- CoV-2 is still unknown. This study aimed to compare molecular and serological testing for the diagnosis of Covid-19.
Materials and Methods: In this study, a total of 100 participants, 50 patients with confirmed SARS-CoV-2 infection using real-time reverse transcriptase PCR (RT-PCR) and 50 controls with negative RT-PCR test, were enrolled. The serum level of IgM and IgG antibodies against nucleocapsid antigens of SARS-CoV-2 were tested using the enzyme-linked immunosorbent assays (ELISAs) and also antibodies were tested again after four months in the case group. This study was carried out in the Asadabadei clinic between April and June 2020.
Results: The Seroconversion rates of IgM in the case and control groups were 14% and 4%, respectively, but the differences were not statistically significant (P =0.134). In the case group, the Seroconversion rate of IgG was significantly higher than the control group (44% vs. 4%) (P <0.001).
Conclusion: Our results revealed that IgM antibodies in the diagnosis of Covid -19, especially in the early stages of the disease have less diagnostic value compared to PCR. It seems that periodic follow-up of serological tests is necessary to know the production of appropriate antibody response in Covid-19 patients as well as in receiving the vaccine.
Keywords: PCR, Covid-19, ELISA, Serologic tests, Iran
Full-Text [PDF 422 kb]   (77 Downloads)    
Type of Study: Original article | Subject: General
Received: 2021/03/9 | Accepted: 2021/07/26 | Published: 2021/12/19
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Laghousi D, Bannazadeh Baghi H, Poortahmasebi V, Azadi A, Nomani R, Ghasemi Nia M, et al . Comparing the molecular and serological testing for detection of SARS - COV-2. Iran J Virol. 2021; 15 (2) :22-27
URL: http://journal.isv.org.ir/article-1-430-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 15, Issue 2 (12-2021) Back to browse issues page
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4419